• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国原发性消化系统淋巴瘤患者的流行病学趋势及生存结果

Epidemiologic trends and survival outcomes in patients with primary digestive system lymphoma in the United States.

作者信息

Jiang Jiao, Peng Jieyu, Huang Shu, Shi Xiaomin, Luo Bei, Xu Jia, Zhang Wei, Shi Lei, Lü Muhan, Tang Xiaowei

机构信息

Department of Gastroenterology, the Affiliated Hospital of Southwest Medical University, Street Taiping No.25, Region Jiangyang, Luzhou, 646099, Sichuan Province, China.

Department of Gastroenterology, Lianshui County People' Hospital, Huaian, China.

出版信息

Clin Transl Oncol. 2025 Jun;27(6):2689-2699. doi: 10.1007/s12094-024-03768-y. Epub 2024 Nov 6.

DOI:10.1007/s12094-024-03768-y
PMID:39503962
Abstract

BACKGROUND AND AIMS

Primary digestive system lymphoma (PDSL) is an important entity of extranodal lymphoma, yet updated epidemiologic and survival data are lacking.

METHODS

Patients diagnosed with PDSL between 1975 and 2020 were identified from the Surveillance, Epidemiology, and End Results database. Kaplan-Meier analysis estimated survival outcomes. Multivariable Cox regression identified independent risk factors, and nomograms were developed to predict 1-, 3-, and 5-year overall survival (OS) and cancer-specific survival (CSS).

RESULTS

A total of 30,568 patients with PDSL were identified, with 57.9% being male and 80.4% white. The most frequent tumor site was the stomach (48.7%) and diffuse large B-cell lymphoma (DLBCL) was the predominant histologic subtype (45.0%). The overall incidence from 2016 to 2020 was 11.11 per 1,000,000 persons, with a decrease observed in lymphoma rates for the stomach, small intestine, large intestine, and pancreas. Long-term trends showed an initial rise in PDSL incidence, followed by a decline since the 1990s. The median OS across all patients was 103 months, with appendiceal lymphoma showing the highest median OS of 253 months. Factors including diagnosis year, age, sex, race, primary tumor site, histologic subtype, stage, and treatment modalities were significantly associated with OS and CSS. Nomograms achieved C-indices of 0.720 for OS and 0.723 for CSS in the training cohort.

CONCLUSION

The incidence of PDSL initially increased but has recently declined. Survival for all PDSL patients has improved over time. Nomograms to predict survival for patients with DLBCL exhibited good predictive and discriminating abilities.

摘要

背景与目的

原发性消化系统淋巴瘤(PDSL)是结外淋巴瘤的一个重要类型,但目前缺乏最新的流行病学和生存数据。

方法

从监测、流行病学和最终结果数据库中识别出1975年至2020年间诊断为PDSL的患者。采用Kaplan-Meier分析估计生存结局。多变量Cox回归确定独立危险因素,并绘制列线图以预测1年、3年和5年总生存率(OS)和癌症特异性生存率(CSS)。

结果

共识别出30568例PDSL患者,其中男性占57.9%,白人占80.4%。最常见的肿瘤部位是胃(48.7%),弥漫性大B细胞淋巴瘤(DLBCL)是主要的组织学亚型(45.0%)。2016年至2020年的总体发病率为每100万人11.11例,胃、小肠、大肠和胰腺的淋巴瘤发病率有所下降。长期趋势显示,PDSL发病率最初上升,自20世纪90年代以来呈下降趋势。所有患者的中位OS为103个月,阑尾淋巴瘤的中位OS最高,为253个月。诊断年份、年龄、性别、种族、原发肿瘤部位、组织学亚型、分期和治疗方式等因素与OS和CSS显著相关。在训练队列中,列线图的OS C指数为0.720,CSS C指数为0.723。

结论

PDSL的发病率最初上升,但最近有所下降。随着时间的推移,所有PDSL患者的生存率都有所提高。用于预测DLBCL患者生存的列线图具有良好的预测和鉴别能力。

相似文献

1
Epidemiologic trends and survival outcomes in patients with primary digestive system lymphoma in the United States.美国原发性消化系统淋巴瘤患者的流行病学趋势及生存结果
Clin Transl Oncol. 2025 Jun;27(6):2689-2699. doi: 10.1007/s12094-024-03768-y. Epub 2024 Nov 6.
2
Primary diffuse large B-cell lymphoma of bone in adults: A SEER population-based study.成人原发性骨弥漫性大 B 细胞淋巴瘤:一项 SEER 基于人群的研究。
Medicine (Baltimore). 2024 Oct 25;103(43):e40071. doi: 10.1097/MD.0000000000040071.
3
The incidence and survival outcomes of patients with primary cardiac lymphoma: A SEER-based analysis.原发性心脏淋巴瘤患者的发病和生存结局:基于 SEER 的分析。
Hematol Oncol. 2020 Aug;38(3):334-343. doi: 10.1002/hon.2741. Epub 2020 Apr 29.
4
Development of a Nomogram-Based Online Calculator for Predicting Cancer-Specific Survival in Patients With Digestive Tract Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms (MiNENs): An Analysis of the SEER Database.基于列线图的在线计算器的开发,用于预测消化道混合性神经内分泌-非神经内分泌肿瘤(MiNENs)患者的癌症特异性生存率:监测、流行病学和最终结果(SEER)数据库分析
Cancer Rep (Hoboken). 2025 Feb;8(2):e70156. doi: 10.1002/cnr2.70156.
5
Nomograms Predict Survival Outcome of Primary Intramedullary Spinal Cord Lymphoma Patients.列线图预测原发性脊髓内淋巴瘤患者的生存结局。
Med Sci Monit. 2019 Oct 3;25:7418-7429. doi: 10.12659/MSM.919628.
6
Epidemiological features of primary breast lymphoma patients and development of a nomogram to predict survival.原发性乳腺淋巴瘤患者的流行病学特征和生存预测列线图的建立。
Breast. 2021 Jun;57:49-61. doi: 10.1016/j.breast.2021.03.006. Epub 2021 Mar 17.
7
Prognostic factors and predictive models for primary pulmonary diffuse large B-cell lymphoma: a population-based analysis.原发性肺弥漫性大 B 细胞淋巴瘤的预后因素和预测模型:一项基于人群的分析。
Hematology. 2024 Dec;29(1):2420160. doi: 10.1080/16078454.2024.2420160. Epub 2024 Oct 28.
8
A nomogram to predict postoperative overall and cancer specific survival in patients with primary parotid squamous cell carcinoma: a population based study.预测原发性腮腺鳞状细胞癌患者术后总体生存率和癌症特异性生存率的列线图:一项基于人群的研究。
Sci Rep. 2025 Feb 25;15(1):6774. doi: 10.1038/s41598-025-90480-8.
9
Epidemiological features and prognosis for primary gastrointestinal follicular lymphoma.原发性胃肠道滤泡性淋巴瘤的流行病学特征和预后。
Br J Haematol. 2024 May;204(5):1771-1779. doi: 10.1111/bjh.19393. Epub 2024 Mar 6.
10
Improved Survival With Radiation Therapy in Stage I-II Primary Mediastinal B Cell Lymphoma: A Surveillance, Epidemiology, and End Results Database Analysis.I 期-Ⅱ期原发性纵隔 B 细胞淋巴瘤采用放射治疗后生存率提高:监测、流行病学和最终结果数据库分析。
Int J Radiat Oncol Biol Phys. 2016 Jan 1;94(1):126-132. doi: 10.1016/j.ijrobp.2015.09.017. Epub 2015 Sep 25.

本文引用的文献

1
Development and validation of a nomogram based on geriatric nutritional risk index for predicting prognosis and postoperative complications in surgical patients with upper urinary tract urothelial carcinoma.基于老年营养风险指数的列线图的开发和验证,用于预测上尿路尿路上皮癌手术患者的预后和术后并发症。
J Cancer Res Clin Oncol. 2023 Dec;149(20):18185-18200. doi: 10.1007/s00432-023-05462-y. Epub 2023 Nov 30.
2
Epidemiology and Determinants of Survival for Primary Intestinal Non-Hodgkin Lymphoma: A Population-Based Study.原发性肠道非霍奇金淋巴瘤的流行病学及生存决定因素:一项基于人群的研究
World J Oncol. 2022 Aug;13(4):159-171. doi: 10.14740/wjon1504. Epub 2022 Aug 23.
3
Primary hepatopancreatobiliary lymphoma: Pathogenesis, diagnosis, and management.
原发性肝胰胆淋巴瘤:发病机制、诊断与治疗
Front Oncol. 2022 Aug 30;12:951062. doi: 10.3389/fonc.2022.951062. eCollection 2022.
4
Site-Specific Survival of Extra Nodal Diffuse Large B-Cell Lymphoma and Comparison With Gastrointestinal Diffuse Large B-Cell Lymphoma.结外弥漫性大B细胞淋巴瘤的部位特异性生存及其与胃肠道弥漫性大B细胞淋巴瘤的比较。
J Hematol. 2022 Apr;11(2):45-54. doi: 10.14740/jh984. Epub 2022 Apr 22.
5
Gastrointestinal Tract Lymphomas.胃肠道淋巴瘤
Arch Pathol Lab Med. 2021 Dec 1;145(12):1585-1596. doi: 10.5858/arpa.2020-0661-RA.
6
Nomogram for Predicting the Overall Survival of Adult Patients With Primary Gastrointestinal Diffuse Large B Cell Lymphoma: A SEER- Based Study.预测原发性胃肠道弥漫性大B细胞淋巴瘤成年患者总生存期的列线图:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Front Oncol. 2020 Jul 3;10:1093. doi: 10.3389/fonc.2020.01093. eCollection 2020.
7
Incidence, Prognostic Factors and Survival Outcome in Patients With Primary Hepatic Lymphoma.原发性肝淋巴瘤患者的发病率、预后因素及生存结果
Front Oncol. 2020 May 14;10:750. doi: 10.3389/fonc.2020.00750. eCollection 2020.
8
Peripheral T-cell lymphoma with gastrointestinal involvement and indolent T-lymphoproliferative disorders of the gastrointestinal tract.伴有胃肠道累及的外周 T 细胞淋巴瘤和惰性胃肠道 T 淋巴细胞增生性疾病。
Leuk Res. 2020 Apr;91:106336. doi: 10.1016/j.leukres.2020.106336. Epub 2020 Feb 29.
9
Development and Validation of Prognostic Nomograms for Patients with Primary Gastrointestinal Non-Hodgkin Lymphomas.原发性胃肠道非霍奇金淋巴瘤患者的预后列线图的建立和验证。
Dig Dis Sci. 2020 Dec;65(12):3570-3582. doi: 10.1007/s10620-020-06078-9. Epub 2020 Jan 28.
10
Gastrointestinal lymphoma: the new mimic.胃肠道淋巴瘤:新的模仿者。
BMJ Open Gastroenterol. 2019 Sep 13;6(1):e000320. doi: 10.1136/bmjgast-2019-000320. eCollection 2019.